ALB and heart failure: FAR and C-reactive protein to albumin ratio have emerged as prognostic immune biomarkers for a variety of diseases, such as solid tumors, leukemia, hypertension, heart failure, ST-segment elevation, myocardial infarction, and sepsis (14–17).